
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $6M | $8.7M | |
Other Inc / (Exp) | -- | -- | -- | $65.9K | -$980.8K | |
Operating Expenses | -- | -- | -- | $6M | $8.7M | |
Operating Income | -- | -- | -- | -$6M | -$8.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$5.9M | -$9.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $72.6K | |
Net Income to Company | -- | -- | -$96.8K | -$5.9M | -$9.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$96.8K | -$5.9M | -$9.9M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.19 | -$0.29 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.19 | -$0.29 | |
Weighted Average Basic Share | -- | -- | $34.2M | $30.4M | $34.2M | |
Weighted Average Diluted Share | -- | -- | $34.2M | $30.4M | $34.2M | |
EBITDA | -- | -- | -- | -$5.9M | -$9.7M | |
EBIT | -- | -- | -$96.8K | -$5.9M | -$9.7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$6M | -$8.7M | |
Operating Income (Adjusted) | -- | -- | -$96.8K | -$5.9M | -$9.7M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $10.2K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $2.7K | |
Gross Profit | -- | -- | -- | -- | $7.5K | |
Gross Profit Margin | -- | -- | -- | -- | 73.55% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $1.1M | $1.5M | $1.5M | $1.6M | |
Other Inc / (Exp) | -- | -$960 | $14.9K | -$135.4K | $5.3M | |
Operating Expenses | -- | $1.1M | $1.5M | $1.5M | $1.7M | |
Operating Income | -- | -$1.1M | -$1.5M | -$1.5M | -$1.7M | |
Net Interest Expenses | -- | -- | -- | -- | $133.2K | |
EBT. Incl. Unusual Items | -- | -$1.1M | -$1.5M | -$1.7M | $3.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -$1.5M | -$1.7M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$1.1M | -$1.5M | -$1.7M | $3.5M | |
Basic EPS (Cont. Ops) | -- | -$0.03 | -$0.05 | -$0.15 | $0.12 | |
Diluted EPS (Cont. Ops) | -- | -$0.03 | -$0.05 | -$0.15 | $0.12 | |
Weighted Average Basic Share | -- | $34.2M | $31.7M | $11.6M | $29.1M | |
Weighted Average Diluted Share | -- | $34.2M | $31.7M | $11.6M | $30.6M | |
EBITDA | -- | -$1.1M | -$1.5M | -$1.7M | $3.7M | |
EBIT | -- | -$1.1M | -$1.5M | -$1.7M | $3.7M | |
Revenue (Reported) | -- | -- | -- | -- | $10.2K | |
Operating Income (Reported) | -- | -$1.1M | -$1.5M | -$1.5M | -$1.7M | |
Operating Income (Adjusted) | -- | -$1.1M | -$1.5M | -$1.7M | $3.7M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $8.9M | $10.7M | |
Other Inc / (Exp) | -- | -$1K | -$829.5K | $792.9K | $6.5M | |
Operating Expenses | -- | -- | -- | $8.9M | $11.8M | |
Operating Income | -- | -- | -- | -$8.9M | -$11.8M | |
Net Interest Expenses | -- | -- | -- | -- | $133.2K | |
EBT. Incl. Unusual Items | -- | -- | -- | -$8.2M | -$5.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$8.2M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$4.6M | -$8.2M | -$5.8M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.15 | -$0.44 | -$0.29 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.15 | -$0.44 | -$0.29 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -$8.1M | -$5.3M | |
EBIT | -- | -- | -$4.7M | -$8.1M | -$5.3M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$8.9M | -$11.8M | |
Operating Income (Adjusted) | -- | -- | -$4.7M | -$8.1M | -$5.3M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $10.2K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $2.7K | |
Gross Profit | -- | -- | -- | -- | $7.5K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $1.1M | $3.7M | $6.7M | $7.1M | |
Other Inc / (Exp) | -- | -$960 | -$829.5K | $764.8K | $7.9M | |
Operating Expenses | -- | $1.3M | $3.7M | $9.2M | $9.6M | |
Operating Income | -- | -$1.1M | -$3.7M | -$9.2M | -$9.6M | |
Net Interest Expenses | -- | -- | -- | -- | $133.2K | |
EBT. Incl. Unusual Items | -- | -$1.1M | -$4.6M | -$8.4M | -$2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $154.8K | $40.9K | |
Net Income to Company | -- | -- | -$4.6M | -$6.8M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$1.3M | -$4.6M | -$8.6M | -$2M | |
Basic EPS (Cont. Ops) | -- | -$0.04 | -$0.15 | -$0.55 | -$0.19 | |
Diluted EPS (Cont. Ops) | -- | -$0.04 | -$0.15 | -$0.55 | -$0.19 | |
Weighted Average Basic Share | -- | $68.4M | $95.3M | $68.8M | $63.6M | |
Weighted Average Diluted Share | -- | $68.4M | $95.3M | $68.8M | $65.1M | |
EBITDA | -- | -$1.1M | -$4.7M | -$9.2M | -$2.1M | |
EBIT | -- | -$1.3M | -$4.7M | -$9.2M | -$2.1M | |
Revenue (Reported) | -- | -- | -- | -- | $10.2K | |
Operating Income (Reported) | -- | -$1.1M | -$3.7M | -$9.2M | -$9.6M | |
Operating Income (Adjusted) | -- | -$1.3M | -$4.7M | -$9.2M | -$2.1M |
Period Ending | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $3.8M | $490K | $21.1K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | $442.3K | $311.7K | $35.1K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $4.2M | $851.1K | $141.9K | |
Property Plant And Equipment | -- | -- | $4.8K | $2.8K | $950 | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | $4.2M | $853.9K | $142.9K | |
Accounts Payable | -- | -- | $177.6K | $490.3K | $5.7M | |
Accrued Expenses | -- | -- | $23.2K | $418.4K | $813.3K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $1M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | $919.3K | |
Total Current Liabilities | -- | -- | $3.4M | $908.7K | $8.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $3.4M | $908.7K | $8.5M | |
Common Stock | -- | -- | $4.6M | -- | -- | |
Other Common Equity Adj | -- | -- | $2.1M | -$83.6K | $43.6K | |
Common Equity | -- | -- | $783.9K | -$54.8K | -$8.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | $783.9K | -$54.8K | -$8.4M | |
Total Liabilities and Equity | -- | -- | $4.2M | $853.9K | $142.9K | |
Cash and Short Terms | -- | -- | $3.8M | $490K | $21.1K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $1.8K | $1.2M | $103K | $4K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $9.2K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | $347.8K | $57.2K | $492.5K | |
Other Current Assets | -- | -- | -- | -- | $204.6K | |
Total Current Assets | -- | $1.8K | $1.6M | $237.8K | $1.1M | |
Property Plant And Equipment | -- | -- | $3.2K | $1.4K | -- | |
Long-Term Investments | -- | -- | -- | -- | $814.4K | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $1.8K | $1.6M | $239.2K | $2.4M | |
Accounts Payable | -- | -- | $234.7K | $4M | $1.3M | |
Accrued Expenses | -- | $12.8K | $161.3K | $457.7K | $6.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $899.2K | $4.1M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $49.7K | $1.8M | |
Total Current Liabilities | -- | $12.8K | $396K | $5.4M | $17.6M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $12.8K | $396K | $5.4M | $17.6M | |
Common Stock | -- | $56.7K | $7.2M | $8.1M | -- | |
Other Common Equity Adj | -- | -- | -- | $5.8M | $45K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -$11K | $1.2M | -$5.1M | -$15.1M | |
Total Liabilities and Equity | -- | $1.8K | $1.6M | $239.2K | $2.4M | |
Cash and Short Terms | -- | $1.8K | $1.2M | $103K | $4K | |
Total Debt | -- | -- | -- | -- | $4.1M |
Period Ending | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$96.8K | -$5.9M | -$9.9M | |
Depreciation & Amoritzation | -- | -- | -- | $1.9K | $1.8K | |
Stock-Based Compensation | -- | -- | -- | $1.8M | $1.3M | |
Change in Accounts Receivable | -- | -- | -- | -$44.2K | -$39.1K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$54.8K | -$3.4M | -$1.5M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | $10 | -- | |
Cash From Investing | -- | -- | -- | $10 | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $933.5K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | $56.6K | $302K | $1.1M | |
Beginning Cash (CF) | -- | -- | -- | $3.8M | $490K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $1.8K | -$3.1M | -$439.3K | |
Ending Cash (CF) | -- | -- | $1.8K | $490K | $21.1K | |
Levered Free Cash Flow | -- | -- | -$54.8K | -$3.4M | -$1.5M |
Period Ending | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$1.3M | -$3M | |
Depreciation & Amoritzation | -- | -- | -- | $460 | $400 | |
Stock-Based Compensation | -- | -- | -- | $580.8K | $241.6K | |
Change in Accounts Receivable | -- | -- | -- | $5.8K | -$8.7K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$1M | -$127.6K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $70K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $302K | $70K | |
Beginning Cash (CF) | -- | -- | -- | $1.2M | $103K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $17.9K | -$24.3K | |
Additions / Reductions | -- | -- | -- | -$717.6K | -$57.6K | |
Ending Cash (CF) | -- | -- | -- | $490K | $21.1K | |
Levered Free Cash Flow | -- | -- | -- | -$1M | -$127.6K |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$8.2M | -- | |
Depreciation & Amoritzation | -- | -- | -- | $1.8K | -- | |
Stock-Based Compensation | -- | -- | $1.3M | $1.6M | $504K | |
Change in Accounts Receivable | -- | -- | -- | -$24.6K | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$2.4M | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $863.5K | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $1.3M | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$1.1M | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$2.4M | -- |
Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$5.9M | -$9.9M | -- | |
Depreciation & Amoritzation | -- | -- | $1.8K | $1.8K | -- | |
Stock-Based Compensation | -- | -- | $1.8M | $1.3M | -- | |
Change in Accounts Receivable | -- | -- | -$44.2K | -$39.1K | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$3.4M | -$1.5M | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | $10 | -- | -- | |
Cash From Investing | -- | -- | $10 | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $933.5K | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | $302K | $1.1M | -- | |
Beginning Cash (CF) | -- | -- | $10.1M | $614.5K | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -$159.5K | -$29.6K | -- | |
Additions / Reductions | -- | -- | -$3.1M | -$439.3K | -- | |
Ending Cash (CF) | -- | -- | $6.9M | $145.6K | -- | |
Levered Free Cash Flow | -- | -- | -$3.4M | -$1.5M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.